Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague

Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague–Dawley rats

Published:2010-09 Issue:3 Volume:96 Page:260-265
ISSN:0091-3057
Container-title:Pharmacology Biochemistry and Behavior
language:en
Short-container-title:Pharmacology Biochemistry and Behavior

Author:

Killinger Bryan A.,Peet Mary M.,Baker Lisa E.

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Biological Psychiatry,Clinical Biochemistry,Pharmacology,Toxicology,Biochemistry

Reference37 articles.

1. Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats;Baker;Psychopharmacology,2009

2. The plant-derived hallucinogen, salvinorin A, produces kappa opioid agonist-like discriminative effects in rhesus monkeys;Butelman;Psychopharmacology,2004

3. The discriminative effects of the k-opioid hallucinogen salvinorin A in nonhuman primates: dissociation from classic hallucinogen effects;Butelman;Psychopharmacology,2010

4. Drug discrimination in neurobiology;Colpaert;Pharmacol Biochem Behav,1999

5. Drug Enforcement Administration. List of drugs and chemicals of concern. 2008; http://www.deadiversion.usdoj.gov/drugs_concern/salvia_d/salvia_d.htm Accessed 18 Jul 2009.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and Pharmacodynamics of Salvinorin A and Salvia divinorum: Clinical and Forensic Aspects;Pharmaceuticals;2021-02-03

2. Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry;The Kappa Opioid Receptor;2021

3. Hallucinogenic Drugs;eLS;2020-09-30

4. Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats;Behavioural Pharmacology;2020-09-21

5. Effects of acute and repeated treatment with serotonin 5-HT2A receptor agonist hallucinogens on intracranial self-stimulation in rats.;Experimental and Clinical Psychopharmacology;2019-06